239 related articles for article (PubMed ID: 23341448)
1. A structural view on the functional importance of the sugar moiety and steroid hydroxyls of cardiotonic steroids in binding to Na,K-ATPase.
Cornelius F; Kanai R; Toyoshima C
J Biol Chem; 2013 Mar; 288(9):6602-16. PubMed ID: 23341448
[TBL] [Abstract][Full Text] [Related]
2. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
Cornelius F; Mahmmoud YA
Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
[TBL] [Abstract][Full Text] [Related]
3. Metal fluoride complexes of Na,K-ATPase: characterization of fluoride-stabilized phosphoenzyme analogues and their interaction with cardiotonic steroids.
Cornelius F; Mahmmoud YA; Toyoshima C
J Biol Chem; 2011 Aug; 286(34):29882-92. PubMed ID: 21708939
[TBL] [Abstract][Full Text] [Related]
4. Binding of cardiotonic steroids to Na
Kanai R; Cornelius F; Ogawa H; Motoyama K; Vilsen B; Toyoshima C
Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33318128
[TBL] [Abstract][Full Text] [Related]
5. Steroid-like compounds in Chinese medicines promote blood circulation via inhibition of Na+/K+ -ATPase.
Chen RJ; Chung TY; Li FY; Yang WH; Jinn TR; Tzen JT
Acta Pharmacol Sin; 2010 Jun; 31(6):696-702. PubMed ID: 20523340
[TBL] [Abstract][Full Text] [Related]
6. Cardiotonic steroid-resistant alpha1-Na+,K+-ATPase rescues renal epithelial cells from the cytotoxic action of ouabain: evidence for a Nai+,Ki+ -independent mechanism.
Akimova OA; Tremblay J; Van Huysse JW; Hamet P; Orlov SN
Apoptosis; 2010 Jan; 15(1):55-62. PubMed ID: 19949978
[TBL] [Abstract][Full Text] [Related]
7. Depth of the Steroid Core Location Determines the Mode of Na,K-ATPase Inhibition by Cardiotonic Steroids.
Tverskoi AM; Poluektov YM; Klimanova EA; Mitkevich VA; Makarov AA; Orlov SN; Petrushanko IY; Lopina OD
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948068
[TBL] [Abstract][Full Text] [Related]
8. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
Paula S; Tabet MR; Ball WJ
Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
[TBL] [Abstract][Full Text] [Related]
9. Spin-labeled derivatives of cardiotonic steroids as tools for characterization of the extracellular entrance to the binding site on Na
Guo JH; Jiang RW; Andersen JL; Esmann M; Fedosova NU
FEBS J; 2018 Jun; 285(12):2292-2305. PubMed ID: 29688626
[TBL] [Abstract][Full Text] [Related]
10. Effect of sugar positions in ginsenosides and their inhibitory potency on Na+/K+-ATPase activity.
Chen RJ; Chung TY; Li FY; Lin NH; Tzen JT
Acta Pharmacol Sin; 2009 Jan; 30(1):61-9. PubMed ID: 19060914
[TBL] [Abstract][Full Text] [Related]
11. Binding of ouabain and marinobufagenin leads to different structural changes in Na,K-ATPase and depends on the enzyme conformation.
Klimanova EA; Petrushanko IY; Mitkevich VA; Anashkina AA; Orlov SN; Makarov AA; Lopina OD
FEBS Lett; 2015 Sep; 589(19 Pt B):2668-74. PubMed ID: 26297827
[TBL] [Abstract][Full Text] [Related]
12. Cardiotonic steroids as potential Na
Patel CN; Kumar SP; Modi KM; Soni MN; Modi NR; Pandya HA
J Recept Signal Transduct Res; 2019 Jun; 39(3):226-234. PubMed ID: 31509043
[TBL] [Abstract][Full Text] [Related]
13. Structures and characterization of digoxin- and bufalin-bound Na+,K+-ATPase compared with the ouabain-bound complex.
Laursen M; Gregersen JL; Yatime L; Nissen P; Fedosova NU
Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1755-60. PubMed ID: 25624492
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the high-affinity Na+K+-ATPase-ouabain complex with Mg2+ bound in the cation binding site.
Laursen M; Yatime L; Nissen P; Fedosova NU
Proc Natl Acad Sci U S A; 2013 Jul; 110(27):10958-63. PubMed ID: 23776223
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the sugar moiety in the inhibitory action of the cardiac glycosides on the palytoxin-induced responses in vascular smooth muscles.
Ozaki H; Nagase H; Urakawa N
J Pharmacol Exp Ther; 1984 Oct; 231(1):153-8. PubMed ID: 6149301
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into the high affinity binding of cardiotonic steroids to the Na+,K+-ATPase.
Yatime L; Laursen M; Morth JP; Esmann M; Nissen P; Fedosova NU
J Struct Biol; 2011 May; 174(2):296-306. PubMed ID: 21182963
[TBL] [Abstract][Full Text] [Related]
18. Hellebrin and its aglycone form hellebrigenin display similar in vitro growth inhibitory effects in cancer cells and binding profiles to the alpha subunits of the Na+/K+-ATPase.
Moreno Y Banuls L; Katz A; Miklos W; Cimmino A; Tal DM; Ainbinder E; Zehl M; Urban E; Evidente A; Kopp B; Berger W; Feron O; Karlish S; Kiss R
Mol Cancer; 2013 Apr; 12():33. PubMed ID: 23621895
[TBL] [Abstract][Full Text] [Related]
19. Interaction of FXYD10 (PLMS) with Na,K-ATPase from shark rectal glands. Close proximity of Cys74 of FXYD10 to Cys254 in the a domain of the alpha-subunit revealed by intermolecular thiol cross-linking.
Mahmmoud YA; Vorum H; Cornelius F
J Biol Chem; 2005 Jul; 280(30):27776-82. PubMed ID: 15919665
[TBL] [Abstract][Full Text] [Related]
20. Cardiac Oxidative Signaling and Physiological Hypertrophy in the Na/K-ATPase α1
Marck PV; Pessoa MT; Xu Y; Kutz LC; Collins DM; Yan Y; King C; Wang X; Duan Q; Cai L; Xie JX; Lingrel JB; Xie Z; Tian J; Pierre SV
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
